Unique Plan Description: dalbavancin (Dalvance)
Plan Selection Display: dalbavancin (Dalvance)
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2020-09-10 08:03:50
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2023-08-08 14:18:01
Available at all facilities: Yes

dalbavancin (Dalvance)
Medications
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.19781(NOTE)*
		Inclusion Criteria considerations:  IV drug use, homelessness, treatment non compliance, transportation concerns, lack of follow up(NOTE)*
		Exclusion Criteria:  Immunocompromised (ANC < 500, Transplat patient, Chemotherapy)Cellulitis over an implanted device or prosthesisPetechiae or purpura50% limb or torso affectedTwo or more of the follow are present: (Temp > 38.7, WBC>13,Bands>1(NOTE)*
	dalbavancin 1500mg IVPB
		1,500 mg, IVPB, Once, T;N, Infuse Over 30 min(s)
		75 mL, EVERY BAG
Patient Care
	Communication to HOSPITAL RN
		Nursing staff to assess and enroll in patient assistance program if uninsured.

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase